menu
    • menu

    Company profile for Crescent Biopharma

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Crescent Biopharma aims to become a world-leading oncology company, delivering next-generation therapies for cancer patients. Its pipeline features a PD-1 x VEGF bispecific antibody and novel antibody-drug conjugates. By leveraging multiple modalities and validated targets, Crescent focuses on advancing transformative treatments either as monotherapies or in combination to address a variety of solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Crescent BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Boston, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.crescentbiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioAsia

    Not Confirmed

    envelop Contact Supplier

    BioAsia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Crescent Bio To Present At Guggenheim Biotech Summit 2026
    Crescent Bio To Present At Guggenheim Biotech Summit 2026

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3232891/0/en/Crescent-Biopharma-to-Present-at-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share
    Crescent Biopharma Announces Grants Of Inducement Awards
    Crescent Biopharma Announces Grants Of Inducement Awards

    30 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/30/3229772/0/en/Crescent-Biopharma-Announces-Grants-of-Inducement-Awards.html

    GLOBENEWSWIRE
    30 Jan 2026
    Share Share
    Kelun-Biotech Gets NMPA Approval For ITGB6-Targeted ADC SKB105
    Kelun-Biotech Gets NMPA Approval For ITGB6-Targeted ADC SKB105

    05 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kelun-biotech-receives-investigational-new-drug-approval-for-itgb6-targeted-adc-skb105-from-the-nmpa-302652410.html

    PR NEWSWIRE
    05 Jan 2026
    Share Share
    Crescent Biopharma Announces IND Clearances for CR-001 and CR-003
    Crescent Biopharma Announces IND Clearances for CR-001 and CR-003

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212621/0/en/Crescent-Biopharma-Announces-Regulatory-Clearances-of-IND-Applications-for-CR-001-a-PD-1-x-VEGF-Bispecific-Antibody-and-CR-003-an-ITGB6-targeted-ADC-for-the-Treatment-of-Solid-Tumo.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Crescent Biopharma Announces Grants Of Inducement Awards
    Crescent Biopharma Announces Grants Of Inducement Awards

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3208188/0/en/Crescent-Biopharma-Announces-Grants-of-Inducement-Awards.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Kelun-Biotech Licenses Cancer Treatment to Crescent Biopharma
    Kelun-Biotech Licenses Cancer Treatment to Crescent Biopharma

    06 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199605/0/en/Crescent-Biopharma-Announces-Transformational-Partnership-with-Kelun-Biotech-and-185-Million-Private-Placement-Accelerating-and-Expanding-Global-Pipeline-of-Next-Generation-Therape.html

    GLOBENEWSWIRE
    06 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search